SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

BlossomHill Therapeutics, Inc. (BLSM)

NASDAQ: BLSM · Real-Time Price · USD
16.25-0.36 (-2.18%)
 
Market Cap472.52M+3.2%
Revenue (ttm)n/a
Net Incomen/a
EPSn/a
Shares Out29.08M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume28,930.072
Open16.52
Previous Close16.61
Day's Range16.20 - 16.63
52-Week Range15.25 - 27.99
Betan/a
AnalystsBuy
Price Target38.33(+135.90%)
Earnings Daten/a
-2.17% (1D)
No price history available.
Insider Score
/ 100
BLSM Insider Score

BlossomHill Therapeutics, Inc. has a live Insider Score.

Scored on 7 qualifying trades from 6 insiders in the last 90 days.

Unlock the score

About BLSM

BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and BH-30236, a macrocyclic CLK (Cdc2-like kinase) inhibitor being evaluated in patients with relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndrome (HR-MDS). BlossomHill Therapeutics, Inc. was incorporated in 2020 and is based in San Diego, California.

Address
10255 Science Center Drive, San Diego, CA, 92121, United States
Market Cap
473 million
Employees
69
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$25.18M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-2.17%
5 Days
-12.59%
1 Month
-26.14%
6 Months
+1.56%
1 Year
+3.17%

$BLSM stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in BLSM holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by BLSM's directors and management

Net Shares Purchased by Insiders−2M−1M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

BLSM Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New BLSM patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BLSM from public contracts

Source: USAspending.gov

BLSM Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for BLSM is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from BLSM’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
7
Sells
0
Buy Value
$25.18M
Distinct Buyers
6

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.